| | DECEMBER 20214CIOReviewContentsCXO INSIGHTS12 COVER STORY24203549Put your frontline teams in the driving seat bycreatinga personalized, customer centric approach to next generation engagementin pharmaThree C's to Enable Continuous Development and Manufacturing for Small Molecule Active Pharmaceutical IngredientAvoiding the `Shiny Object' Trap of Digital TransformationTimothy White, Vice President & Head of Global Digital Commercial, Teva PharmaceuticalsHow Technology Enhancesthe Effectiveness of Compliance ProgramsHow Small Pharma, Working Within a Global Pharma, Can Benefit From One Pharmacovigilance SystemTatiana Sorokina, Solutions Director, Data Science & Artificial Intelligence, DSAI Innovation Execution, NovartisNick Thomson, Senior Director, Chemical Research and Development, Pfizer IncPatrik Florencio, SVP and Chief Compliance & Risk Officer, Amicus Therapeutics and Michael Schneider, Executive Director, Global ERM and Compliance Auditing, Amicus TherapeuticsMai Huang, M.D., Executive Director, Drug Safety and Pharmacovigilance, Avanir Pharmaceuticals28Harnessing the Full Potential of HPCRe-Store Michael Sedlmayer, President and Chief Architect
< Page 3 | Page 5 >